Tuberculosis Trial, Recruiting NCT05989802 Sponsor: University of California, San Francisco Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT05989802
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children (under 15 years old):

  • Children who have 2 or more of the following: an unexplained cough of any length of time, known contact with someone who has TB or a positive TB skin test or TB blood test, or an abnormal chest X-ray of any kind
  • Children who have at least 1 of the symptoms above AND at least 1 of the following: unexplained weight loss or poor growth or severe malnutrition, unexplained fever lasting 2 weeks or more, or unexplained tiredness or reduced energy/playfulness lasting 2 weeks or more

For health workers (a separate part of the study):

  • Health workers aged 18 or older who are involved in routine TB testing at the clinic, such as collecting samples or carrying out TB tests
  • Health workers who are willing to give their informed consent to participate

Who may not be able to join:

For children:

  • Children who have completed a course of TB prevention or TB treatment within the past 12 months
  • Children who have taken any medication that fights TB-related bacteria for more than 3 days at the time of joining the study
  • Children whose family situation means they would be unable to return for follow-up visits
  • Children whose parents or guardians are unwilling to give consent, or children of an age (as determined by the local ethics board) who are themselves unwilling to agree to participate

For health workers:

  • Health workers who are unwilling to give their informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adithya Cattamanchi, MD, MAS, University of California, Irvine

Phone: 415-514-4692

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 January 2024
Est. completion
1 September 2026

Where this trial is recruiting

Mozambique 🇿🇦 South Africa Uganda

Primary endpoints

Proportion with positive index test result among participants with tuberculosis (TB); Proportion with negative index test result among participants without tuberculosis (TB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov